Shineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection Treatment

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: For oral administration
Still deciding? Get samples of US$ 0/Piece
Request Sample
Manufacturer/Factory, Trading Company

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, GMP, ISO 13485, FSC
Import & Export Mode
Have Own Export License
  • Shineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection Treatment
  • Shineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection Treatment
  • Shineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection Treatment
  • Shineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection Treatment
  • Shineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection Treatment
  • Shineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection Treatment
Find Similar Products

Basic Info.

Model NO.
AMC12061-04
State
Solid
Shape
Tablet
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Packing
875mg+125mg, 7′s*2/Box, 200boxes/CTN
CTN Size
56*55*35cm
OEM/ODM
Support
Shelf Life
3 Years
Transport Package
7′s*2/Box
Specification
875mg+125mg
Trademark
Medipharm or OEM
Origin
China
HS Code
3004101200
Production Capacity
100000ctns/Month

Product Description

Shineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection Treatment
SHINEAMOXI AND CLAVULANATE POTASSIUM TABLET
Name Shineamoxi and Clvulanate Potassium Tablet
Specification 875mg+125mg, 7's*2/box, 200boxes/ctn
Ctn Size 56*55*35cm
Brand Medipharm or OEM
Transport Shipping
Indications:
It's indicated for the treatment of infections caused by Shineamoxi resistant organisms producing beta-lactamases sensitive to clavulanic acid:Upper respiratory tract infections: otitis media, tonsillitis, sinusitis.Lower respiratory tract infections: bronchitis(caused by Shineamoxi resistant beta-lactamases producing E.coli, H influenzae and Haemophilus parainfluenzae), pneumonia.
Skin and soft tissue infections.
Urinary tract infections: cystitis, urethritis, pyelonephritis.
Shineamoxi Clvulanate formulations will also be effective in the treatment of infections caused by Shineamoxi sensitive organisms at the appropriate Shineamoxi dosage since in this situation the clavulanic acid component does not contribute to the therapeutic effect.
Adverse reactions:
Allergy to penicillins and cephalosporins. Safety in pregnancy has not been established. Shineamoxi and Clavulanate is contra-indicated in patients with a previous history of Shineamoxi and potassium clavulanate associated jaundice/hepatic dysfunction. Shineamoxi and Clavulanate is also contraindicated in infectious mononucle-osis, Patients with lymphatic leukemia and patients with hyperuricaemia having been treated with allopurinol may also be at an increased risk of developing skin rashes.
Warnings:
Allergy to penicillins and cephalosporins. Safety in pregnancy has not been established. Shineamoxi and Clavulanate is contra-indicated in patients with a previous history of Shineamoxi and potassium clavulanate associated jaundice/hepatic dysfunction. Shineamoxi and Clavulanate is also contraindicated in infectious mononucle-osis, Patients with lymphatic leukemia and patients with hyperuricaemia having been treated with allopurinol may also be at an increased risk of developing skin rashes.
Storage:
Store below 25ºC in the original package. Protect from light. Keep out of reach of Children.
 
-------------------------------------------------------------------------------------------------


Shineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection TreatmentShineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection TreatmentShineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection TreatmentShineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection TreatmentShineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection TreatmentShineamoxi and Clavulanate Potassium Tablet 875mg+125mg for Infection Treatment

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier